Pharmaceutical firm Johnson & Johnson will start delivery out 4 million doses of its COVID-19 vaccine throughout America beginning on Monday, after receiving emergency approval for the drug from the F.D.A. on Saturday. The corporate says it expects to have 20 million doses distributed by the tip of March, and an extra 100 doses over the course of the summer time, NBC reviews.
On Wednesday, the FDA launched its evaluation of the vaccine, deeming it 72% efficient within the U.S. at stopping reasonable to extreme sickness from COVID-19, excluding the brand new variants. The Johnson & Johnson vaccine, developed with Janssen Prescription drugs, is a single-shot vaccine, in contrast to the vaccines already being administered within the U.S., which require two pictures spaced weeks aside. And in contrast to the Pfizer and Moderna vaccines, the Johnson & Johnson vaccine can be saved in a traditional fridge, which officers hope will make distribution simpler to rural areas and different underserved locations.
“The authorization of this vaccine expands the provision of vaccines, the most effective medical prevention technique for COVID-19, to assist us within the combat towards this pandemic, which has claimed over half 1,000,000 lives in america,” Appearing FDA Commissioner Janet Woodcock stated in a press release.
In NYC, the de Blasio administration is relying on the brand new vaccine to “supercharge” its vaccination effort, with plans to carry the vaccine on to homebound seniors.
“We’ve been working with quite a lot of completely different businesses and clinicians who’ve the expertise of already caring for individuals of their properties—for instance, home-based main care clinicians in addition to visiting nurses who already present many healthcare companies in individuals’s properties,” NYC Well being Commissioner Dr. Dave Chokshi instructed reporters final week.
The Johnson & Johnson vaccine’s general efficacy price of 66% will not be as excessive because the Pfizer and Moderna vaccines, which have been proven to be over 90% efficient in scientific trials. However all three vaccines are very efficient at stopping extreme sickness, and well being consultants say the easiest way to battle the pandemic is to vaccinate as many individuals as potential as shortly as potential, earlier than new virus variants turn into dominant and extra proof against the present vaccines.
Dr. Paul Offit, who serves on the FDA’s advisory panel, instructed NPR the Johnson & Johnson vaccine “may be very efficient … at stopping extreme illness after a single dose and it induces the form of response, so-called mobile immune response, that appears like it may have pretty long-lived reminiscence, which is all good. This actually offers safety towards what you care about, which is hospitalization, ICU admission and demise. It is just about 100% efficient at doing that.”
In an interview on Meet the Press on Sunday, Dr. Anthony Fauci urged individuals to take any vaccine they’ll get their arms on, and argued that Johnson & Johnson will not be a “weaker” vaccine.
“All three of them are actually fairly good, and folks ought to take the one which’s most obtainable to them,” Fauci, the director of Nationwide Institute of Allergy and Infectious Illnesses, stated. “In the event you go to a spot and you’ve got J&J, and that is the one which’s obtainable now, I might take it. I personally would do the identical factor. I feel individuals have to get vaccinated as shortly and as expeditiously as potential.”
It is unclear what number of doses of the Johnson & Johnson vaccine NYC expects to obtain subsequent week. A de Blasio spokesperson stated on Sunday the mayor “can have extra to say quickly.”
As of Sunday morning, 1.8 million complete doses of COVID-19 vaccine have been given out in NYC. Roughly 68 million vaccine doses have been administered nationwide, NBC Information reviews.